Events
Mötesplats ATMP i Väst 2026 brings together industry and healthcare experts to enable structured dialogue on advanced therapy medicinal products relevant for Swedish healthcare.
We would like to invite you to this event and welcome you to submit an abstract for a presentation, oral or poster, to join the presenters already registered.
Are you working with advanced therapies – for example, cell, gene or tissue-based medicines – or enabling technologies in West Sweden?
News
Sweden is strengthening its position in advanced bioanalytics with the launch of the BioAnalytical Cluster of Excellence (BACE), supported by Vinnova.
Want to strengthen your expertise in hospital-based ATMP and cell therapy manufacturing? This three-day course in April 2026 offers practical insight into regulation, quality systems and clinical application.
Mötesplats ATMP i Väst 2026 brings together industry and healthcare experts to enable structured dialogue on advanced therapy medicinal products relevant for Swedish healthcare.
VERIGRAFT has taken an important step in its clinical program by submitting an application for a pivotal Phase II/III clinical trial in Europe, focused on a patient‑specific tissue‑engineered vein therapy for severe venous disease.
What’s the current state of advanced cell & gene therapies in Sweden? Learn more in the latest episode of Rådet från NT-Rådet Podcast.
A new national partnership, Cell & Gene Therapy SWEDEN, is being established to strengthen Sweden’s global competitiveness in advanced therapies through coordinated collaboration between academia, healthcare, and industry.
What are ATMPs?
Learn more about the Health Technology Assessment related issues of your ATMP development.
Support in navigating ATMP development needs prompting the right competence, need and time.
Find or advertise ATMP relevant job opportunities.
Subscribe to our newsletter
The ATMP newsletter is a quarterly newsletter updating on Swedish ATMP developments.
Sign up